Breast cancer stem cells produce a laminin (LM) 511 matrix, which acts as a ligand for integrin α6Bβ1, promoting self-renewal of breast cancer stem cells and breast cancer development by binding to integrin α6Bβ1 and activating the Hippo signaling factor TAZ (Chang et al., 2015). Here, LAMB2 is linked to breast carcinoma.